Shinpoong Pharmaceutical Co (XKRX:019170) Other Operating Expense : ₩49,139 Mil (TTM As of Mar. 2024)

View and export this data going back to 1990. Start your Free Trial

What is Shinpoong Pharmaceutical Co Other Operating Expense?

Shinpoong Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was ₩11,953 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩49,139 Mil.

Shinpoong Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (₩12,411 Mil) to Dec. 2023 (₩12,417 Mil) but then declined from Dec. 2023 (₩12,417 Mil) to Mar. 2024 (₩11,953 Mil).

Shinpoong Pharmaceutical Co's annual Other Operating Expense increased from Dec. 2021 (₩44,408 Mil) to Dec. 2022 (₩46,265 Mil) and increased from Dec. 2022 (₩46,265 Mil) to Dec. 2023 (₩48,527 Mil).

Shinpoong Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Shinpoong Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shinpoong Pharmaceutical Co Other Operating Expense Chart

Shinpoong Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

38,524.93

35,654.25

44,408.36

46,264.60

48,527.19

Shinpoong Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															11,341.86	12,357.72	12,410.60	12,417.01	11,953.18

Shinpoong Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩49,139 Mil.

Shinpoong Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Shinpoong Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Shinpoong Pharmaceutical Co (XKRX:019170) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shinpoong Pharmaceutical Co Ltd (XKRX:019170) » Definitions » Other Operating Expense

Traded in Other Exchanges

019175:Korea

Address

161, Yeoksam-ro, Gangnam-gu, Seoul, KOR, 06246

Website

https://shinpoong.co.kr

Shinpoong Pharmaceutical Co Ltd specializes in manufacturing remedy drugs and also active pharmaceutical ingredients and finished products. Its products include Newsicam, Caravenal, Roxagen, Clamoxin duo, Ceroxim, and Clocin. The firm's production facilities are located at Gyeonggi-do and Cheongwon-gun.

Shinpoong Pharmaceutical Co (XKRX:019170) Headlines

No Headlines